Walker Luke Nathaniel Insider Profile

4 Followers
Walker Luke Nathaniel, SVP, Clinical Development at Cascadian Therapeutics, holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC), holds ― shares in Harpoon Therapeutics (Ticker: HARP).
Walker Luke Nathaniel

Walker Luke Nathaniel
Cascadian Therapeutics (CASC)
SVP, Clinical Development

Not Ranked
Walker Luke Nathaniel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Walker Luke Nathaniel does not currently own shares as a corporate insider.
A breakdown of Walker Luke Nathaniel's holdings

Insider Roles

Harpoon Therapeutics
(HARP)
CMO
Roles that Walker Luke Nathaniel holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Walker Luke Nathaniel

Walker Luke Nathaniel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CASC
Cascadian Therapeutics
Mar 13, 2018
Uninformative Sell
$0.00
Harpoon Therapeutics
CMO
List of latest transactions for each holding click on a transaction to see Walker Luke Nathaniel's performance on stock

Walker Luke Nathaniel insider profile FAQ

What is the percentage of profitable transactions made by Walker Luke Nathaniel?
The percentage of profitable transactions made by Walker Luke Nathaniel is ―.
    What is the average return per transaction made by Walker Luke Nathaniel?
    The average return per transaction made by Walker Luke Nathaniel is ―.
      What stocks does Walker Luke Nathaniel hold?
      Walker Luke Nathaniel holds: CASC, HARP stocks.
        What was Walker Luke Nathaniel’s latest transaction?
        Walker Luke Nathaniel latest transaction was an Uninformative Sell of ―.
          What was Walker Luke Nathaniel's most profitable transaction?
          Walker Luke Nathaniel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Walker Luke Nathaniel's role in Cascadian Therapeutics?
            Walker Luke Nathaniel's role in Cascadian Therapeutics is SVP, Clinical Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.